Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.

MLA

Kennedy, Jacob J., et al. “Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.” Clinical Chemistry, vol. 67, no. 7, July 2021, pp. 1008–18. EBSCOhost, https://doi.org/10.1093/clinchem/hvab047.

APA

Kennedy, J. J., Whiteaker, J. R., Kennedy, L. C., Bosch, D. E., Lerch, M. L., Schoenherr, R. M., Lei Zhao, Lin, C., Chowdhury, S., Kilgore, M. R., Allison, K. H., Pei Wang, Hoofnagle, A. N., Baird, G. S., & Paulovich, A. G. (2021). Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues. Clinical Chemistry, 67(7), 1008–1018. https://doi.org/10.1093/clinchem/hvab047

Chicago

Kennedy, Jacob J., Jeffrey R. Whiteaker, Laura C. Kennedy, Dustin E. Bosch, Melissa L. Lerch, Regine M. Schoenherr, Lei Zhao, et al. 2021. “Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.” Clinical Chemistry 67 (7): 1008–18. doi:10.1093/clinchem/hvab047.